ACET vs CDROW โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACET Captures Institutional Edge (3โ1 Pillars ยท 8โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Adicet Bio, Inc. Common Stock (ACET) driven by superior Valuation, Growth & Margin, Momentum & Technical while CDROW counters with relative strength in Options & Structure. Fundamentally, ACET trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus CDROW at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ACET sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro) against CDROW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ACET | CDROW | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $23.0M | N/A | Larger Scale | ACET |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -100.0% | N/A | Higher Growth | ACET |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | ACET |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | ACET |
| Return on Equity (ROE) Capital Efficiency | -85.9% | N/A | Higher ROE | ACET |
| 52-Week Range Position Momentum | 18% ($0โ$10) | 2% ($0โ$1) | Stronger Trend | ACET |
| Beta / 30D Volatility Risk Regime | 1.93ฮฒ ยท 60% Vol | 2.28ฮฒ ยท 668% Vol | Lower Realized Risk | ACET |
| Unified Institutional Score Composite Signal | 40.1 / 100 (SELL) | 31.8 / 100 (SELL) | Higher Composite | ACET |